There is accumulating evidence that vitamin D exerts important pathophysiological effects on cardiovascular system. Low vitamin D was associated with increased cardiovascular risk in several reports. We studied the association between vitamin D and arterial stiffness in a random sample of 560 subjects selected from general population. Arterial stiffness was measured as aortic pulse-wave velocity (PWV) using Sphygmocor device. 
Introduction
Low vitamin D status becomes a worldwide problem. The prevalence of hypovitaminosis D is directly related to the distance from equator, but it also exists in latitudes, which enjoy enough sunshine to allow the endogenous synthesis throughout the year. There is increasing evidence that vitamin D status has a role not only in context of bone health, but also in cancer, autoimmune diseases, glucose metabolism abnormalities and namely in cardiovascular diseases. The active form of vitamin D, 1,25-dihydroxyvitamin D (calcitriol) is the end-product of two hydroxylation steps, a hepatic 25-hydroxylation and renal 1a-hydroxylation. 25-hydroxyvitamin D (25(OH)D) is relatively stable, and its serum concentrations are widely used as a marker of vitamin D status. Calcitriol exerts its effect through cytosolic and membrane-bound receptor that is,vitamin D receptor, which has been found in almost all human tissues and cells, among them in vascular smooth muscle cells, cardiomyocytes and endothelial cells. 1 Recent epidemiologic studies reported the relation of low vitamin D status to cardiovascular morbidity and mortality. In a prospective Framingham Offspring study, the individuals with low vitamin D status (25(OH)Do37.5 nmol l À1 ) had a 62% increase in risk of incident cardiovascular disease. 2 Another large study with 418 000 participants free of manifest cardiovascular disease reported more than two-fold increased risk of myocardial infarction in subjects with low 25(OH)D (o37.5 nmol l À1 ), compared with subjects with sufficient levels (X75 nmol l
À1
). 3 Recent prospective study of about 3200 patients scheduled for coronary angiography reported that subjects in lower two quartiles of 25(OH)D (o33 nmol l
) showed more than doubled total and cardiovascular mortality rates during 8 years of follow up. 4 Progressive stiffening is a natural part of vascular aging. Several studies identified increased stiffness of large arteries as independent predictor of cardiovascular disease. Laurent et al. 5 reported that in hypertensive patients, a 5-m s À1 increase of carotidfemoral pulse-wave velocity (PWV) was associated with 2.35 times higher risk of cardiovascular death, and this relationship was confirmed several times in various settings (patients with end-stage renal disease or coronary heart disease, elderly subjects and also in general population).
In order to understand better the assumed role of low vitamin D status in cardiovascular disease, we aimed to study the association between serum 25(OH)D and arterial stiffness, quantified as aortic PWV, in a random sample of general population.
Methods

Subjects
The study population consisted from random general population sample. A survey of risk factors was undertaken in 2008 as a part of Czech post-MONICA study. 6 One percent of residents of City of Pilsen, aged 25-75 years, and stratified by age decades and sex, were selected from the General Health Insurance Registry. A total of 1328 subjects (621 men and 707 women, mean age 55.1 years) responded to the survey. A random subsample, in which arterial properties were examined and 25(OH)D was assessed, was evaluated in the present analysis.
Examinations and materials
All study procedures were done according to Good Clinical Practice regulation and were approved by the local Ethical Committee. Informed consent was obtained from all subjects, and all personal data were stored under the provisions of the Czech Data Protection Act. All responders were interviewed and examined by standardized methods using WHO MONICA (multinational monitoring of trends and determinants in cardiovascular disease) standard manual; the methods were described in details elsewhere. 6 Aortic PWV was measured using Sphygmocor device (AtCor Medical Ltd., Westmead, Sydney, Australia). We measured it with the patient in supine position in the aorta, that is, between carotid and femoral arteries, as recommended by the consensus document. 7 The distance from the jugular fossa to the pulsation of the femoral artery in the groin was measured on body surface, and the distance from the jugular fossa to carotid pulsation was subtracted, as the pulse runs here in the direction opposite to that in the aorta. For direct carotid-femoral distance measurement, the value of 12 m s À1 was suggested as a cutoff for increased aortic stiffness. 8 This value corresponds roughly to 9 m s À1 when subtraction of distances is used. Although the direct measurement becomes an international standard, subtraction of distances is the most accurate method to estimate the true length of aorta, as assessed by magnetic resonance (MRI). 9 Recently, the formulas to convert one distance measurement to another have been published. 10 Distance measurement is the most important source of measurement error of PWV. As it is done on body surface with a tape measure, obese people may have artificially longer distance. Although other methods for distance measurement were suggested, 11 the measurement on body surface is recommended by the expert documents. 7, 10 The PWV measurement was also shown to have good reproducibility. 12 Venous blood samples were drawn in fasting state, and frozen serum samples stored at -80 degrees were used for biochemical laboratory analyses in the series. 25 
Data analysis
The study was designed as a cross-sectional analysis. Statistical analysis of the data was done using STATISTICA 9 (Tulsa, OK, USA) and STATA 6 (College Station, TX, USA) software packages. Power calculation was done using s.d., ascertained in our previous studies. The significance of differences among specific groups was evaluated by Fisher's w 2 -test for categorical variables and by Mann-Whitney U test for continuous variables. Multiple stepwiselogistic regression was used to ascertain the association between 25(OH)D and large artery properties after adjustment for potential confounders. Thirteen subjects with creatinine clearance o40 ml min
À1
were excluded from the final analysis.
Results
A total of 560 subjects, 239 men and 321 women, were evaluated in the present study. Characteristics of study sample as a whole, and according to 25(OH)D quartiles are given in Table 1 . With increasing 25(OH)D levels, a statistically significant decreasing trends were found for age, history of vascular diseases, current smoking, body mass index, systolic blood pressure and pulse pressure, use of antihypertensives, lipid lowering drugs and antidiabetics, total and LDL cholesterol, fasting glucose and namely in aortic PWV.
The relation between aortic PWV and 25(OH)D is shown in Figure 1 . A statistically significant negative association was found between these two variables, Spearman's correlation coefficient was À0.115 (with P value 0.024, adjusted for age and mean arterial pressure).
The association between high aortic PWV (defined as PWVX9 m s À1 , that is, top quartile) and low D vitamin status, defined as 25(OH)D o0 20 ng ml À1 , remained significant after adjustment for conven- Table 1 . All of them were included into regression analysis of aortic PWV, but the only parameters that entered the stepwise regression were age, overweight or obesity, hypertension and low vitamin D status. Thus, vitamin D concentration ranks among the most important determinants of aortic stiffness in our setting.
The role of vitamin D in vascular stiffening is supposed to be multifactorial and we may only speculate on its exact mechanism. Deposition of calcium, especially into arterial media, seems to be the most plausible mechanism. It is characterized by concentric calcium deposition in the arterial vascular smooth muscle cell layer. Matrix metalloproteinases, 15 found in a group of healthy adults that low vitamin D status was associated with increased circulating levels of MMP-9, and vitamin D supplementation during 1 year resulted into their marked decrease. On the other hand, several protective factors, such as matrix Gla protein, osteopontin, osteoprotegerin and collagen IV are able to inhibit vascular calcification. 16 There are also non-calciotropic mechanisms, which may explain the association between vitamin D and arterial stiffness: calcitriol probably directly modulates the vascular smooth muscle cell production 17 and reduces the adverse impact of advanced glycation end-products on vascular aging. 18 There are only few clinical studies dealing with the association between vitamin D and large artery properties, and most of them were done in patients with end-stage renal disease. London et al. 19 reported that increased arterial stiffness measured by PWV was significantly associated with vitamin D deficiency in end-stage renal disease patients. Andrade et al. 20 found a similar association between circulating calcitriol and augmentation index in outpatients with end-stage renal disease or cardiovascular disease. Increased arterial stiffness is an important independent predictor of all-cause mortality in end-stage renal disease, 21 and it has recently become evident that these patients benefit from injectable vitamin D in terms of survival. 22 In a recently published paper, the association of vitamin D with aortic PWV was studied in three ethnic groups: South Asians, African Caribbeans and Europeans. 23 The first group had highest aortic PWV and lowest 25(OH)D level. 25(OH)D correlated negatively with PWV in the whole sample, and it weakened or removed ethnic differences in PWV in regression models. Other two small interventional studies were performed. Braam et al. 24 reported that supplementation of vitamins D and K had a beneficial effect on distensibility of common carotid artery, quantified by Young's elastic modulus, when compared with placebo. A recent study on 24 black adolescents reported a significant decrease of aortic PWV during a 16-week vitamin D supplementation. 25 The crucial question is whether subjects with relatively mild hypovitaminosis, such as in our series, may have any benefit from vitamin D supplementation in terms of cardiovascular risk. A meta-analysis of 18 randomized controlled trials with vitamin D supplementation for osteoporosis in general population showed a significant 7% decrease in all-cause mortality, which is probably a higher benefit than can be expected from simple reduction of osteoporotic fractures. 26 It is possible that reduction also in cardiovascular risk contributes to the observed benefit of vitamin D supplementation. Another meta-analysis raised the question of potential reduction in blood pressure in subjects treated with vitamin D. 27 The achieved mean reduction of systolic blood pressure was 3 mm Hg, which may result in an approximately 10% reduction in cardiovascular mortality. However, the importance of vitamin D supplementation in general population remains to be elucidated by further studies.
Our study has several limitations. They are mainly its cross-sectional observational design; a causal relationship between vitamin D status in general population and increased arterial stiffness can be confirmed only by an interventional trial. The nutritional behavior of our subjects in terms of vitamin D intake (for example, fish consumption) was not ascertained, and the data could not be evaluated from this point of view. Only five subjects were treated with vitamin D supplementation; all were in the top vitamin D quartile. On the other hand, the whole study was performed over 2-3 months during autumn 2008, and thus we can disregard the seasonal variability of vitamin D as confounding factor. We are not able to study the mutual relationship between vitamin D status, arterial stiffness and osteoporosis. The recent report by Briet et al. 28 found a significant age-independent association between remodelling of arterial wall (quantified by carotid internal diameter) and bone mass density in patients with chronic kidney disease. We can speculate that vitamin D has a role in this relationship; however, we have no available data (that is, bone mass density measurements or markers, prevalence of osteoporosis and so on) to study this issue in our setting.
In conclusion, we found that a mild decrease in vitamin D concentrations was independently associated with significantly higher aortic stiffness in a random sample of general population; this may have adverse effect on individual cardiovascular risk. What this study adds K Only mild decrease in vitamin D status was found to be independently associated with significantly higher aortic rigidity in general population.
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